Clinical Trial Update: Lamictal Bipolar Observational Study

View source ↗

Summary

The document reports that an observational clinical trial evaluating Lamictal (lamotrigine) for bipolar disorder has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Drugs mentioned

• LAMICTAL (LAMOTRIGINE)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Bipolar Disorder | Status: COMPLETED